Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY (AJMB)   JANUARY-MARCH 2013 , Volume 5 , Number 1 (16); Page(s) 29 To 34.
 
Paper: 

GENERATION OF A URACIL AUXOTROPH STRAIN OF THE PROBIOTIC YEAST SACCHAROMYCES BOULARDII AS A HOST FOR THE RECOMBINANT PROTEIN PRODUCTION

 
 
Author(s):  HAMEDI HASSAN, MISAGHI ALI, MODARRESSI MOHAMMAD HOSSEIN, ZAHRAEI SALEHI TAGHI, KHORASANIZADEH DORSA, KHALAJ VAHID*
 
* FUNGAL BIOTECHNOLOGY GROUP, BIOTECHNOLOGY RESEARCH CENTER, PASTEUR INSTITUTE OF IRAN, TEHRAN, IRAN
 
Abstract: 
Background: Saccharomyces boulardii (S.boulardii) is the best known probiotic yeast.
The genetic engineering of this probiotic strain requires the availability of appropriate mutants to accept various gene constructs carrying different selection markers. As the auxotrophy selection markers are under focus, we have generated a ura3 auxotroph mutant of S. boulardii for use in further genetic manipulations.
Methods: Classical UV mutagenesis was used for the generation of auxotroph mutants.
The mutants were selected in the presence of 5-FOA (5-Fluoroorotic acid), uracil and uridine. Uracil auxotrophy phenotype was confirmed by the ability of mutants to grow in the presence of uracil and the lack of growth in the absence of this compound. To test whether the uracil auxotrophy phenotype is due to the inactivation of URA3, the mutants were transformed with a plasmid carrying the gene. An in vitro assay was used for the analysis of acid and bile resistance capacity of these mutants Results: Three mutants were found to be ura3 auxotroph as they were able to grow only in the presence of uracil. When the URA3 gene was added, these mutants were able to grow normally in the absence of uracil. Further in vitro analysis showed that the acid and bile resistance capacity of one of these mutants is intact and similar to the wild type.
Conclusion: A uracil auxotroph mutant of the probiotic yeast, S.
boulardii, was generated and characterized. This auxotroph strain may have potential applications in the production and delivery of the recombinant pharmacuetics into the intestinal lumen.
 
Keyword(s): PROBIOTIC, RECOMBINANT PROTEINS, URACIL, YEASTS
 
 
References: 
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

HAMEDI, H., & MISAGHI, A., & MODARRESSI, M., & ZAHRAEI SALEHI, T., & KHORASANIZADEH, D., & KHALAJ, V. (2013). GENERATION OF A URACIL AUXOTROPH STRAIN OF THE PROBIOTIC YEAST SACCHAROMYCES BOULARDII AS A HOST FOR THE RECOMBINANT PROTEIN PRODUCTION. AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY (AJMB), 5(1 (16)), 29-34. https://www.sid.ir/en/journal/ViewPaper.aspx?id=276692



Vancouver: Copy

HAMEDI HASSAN, MISAGHI ALI, MODARRESSI MOHAMMAD HOSSEIN, ZAHRAEI SALEHI TAGHI, KHORASANIZADEH DORSA, KHALAJ VAHID. GENERATION OF A URACIL AUXOTROPH STRAIN OF THE PROBIOTIC YEAST SACCHAROMYCES BOULARDII AS A HOST FOR THE RECOMBINANT PROTEIN PRODUCTION. AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY (AJMB). 2013 [cited 2021August04];5(1 (16)):29-34. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=276692



IEEE: Copy

HAMEDI, H., MISAGHI, A., MODARRESSI, M., ZAHRAEI SALEHI, T., KHORASANIZADEH, D., KHALAJ, V., 2013. GENERATION OF A URACIL AUXOTROPH STRAIN OF THE PROBIOTIC YEAST SACCHAROMYCES BOULARDII AS A HOST FOR THE RECOMBINANT PROTEIN PRODUCTION. AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY (AJMB), [online] 5(1 (16)), pp.29-34. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=276692.



 
  pdf-File
Yearly Visit 82
 
 
Latest on Blog
Enter SID Blog